PRKN and Parkinson disease: Thus, we suppose that the observed dysregulated expression of 3′-HOX genes in the neuronal derivatives from PD patients appears to be caused by disturbance of RA-WNT/ β-catenin signaling; in particular, PARK2 inactivation can lead to an abnormal increase of the β-catenin quantity and subsequent enhanced HOX gene expression.